nordic labs bpc 157 BPC-157 – Mark Hyman, MD BPC 157 (Body Protection Compound-157)

All findings described here are from controlled preclinical research settings

Create a premium recovery and performance retail lane that aligns with training goals

Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus

The data isn't bulletproof (preparation methods vary, study quality is uneven), but it's further along than BPC-157's primarily animal evidence base

NAD+ is a critical coenzyme involved in hundreds of enzymatic reactions including glycolysis, the citric acid cycle, and oxidative phosphorylation, as well as serving as a substrate for NAD+-consuming enzymes including sirtuins, PARPs, and CD38